• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际骨肉瘤发病率趋势(1988-2012 年)。

International trends in incidence of osteosarcoma (1988-2012).

机构信息

Department of Collective Health, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.

Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.

出版信息

Int J Cancer. 2021 Sep 1;149(5):1044-1053. doi: 10.1002/ijc.33673. Epub 2021 May 17.

DOI:10.1002/ijc.33673
PMID:33963769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9137041/
Abstract

Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. The etiology of OS is largely unknown but may be informed by comparisons of incidence and trends between geographic regions. Using the Cancer Incidence in Five Continents (CI5) data from 1988 to 2012, we present OS age-standardized incidence rates (ASRs; cases/million) and average annual percent change (AAPC) and 95% confidence interval (CI) by geographic region among the age groups 0-9, 10-19, 20-29, 30-59, 60-79, 0-79. Among the 10-19 age group, we also used the most recent data (2008-2012) to present the ASRs for each country. We observed little variation in OS incidence between geographic regions in 2008-2012 across all age groups. Overall, the ASR for 0-79 ranged from 2 cases per million in Southern Asia to 4.2 in Sub-Saharan Africa. A bimodal distribution in incidence was observed with peaks in the 10-19 and 60-79 age groups across all regions over time. Overall, OS incidence was relatively stable across 1988-2012 with the only statistically significant increases in the 0-79 age group observed in Eastern Asia (AAPC: 1.8; 95% CI: 0.6, 1.9) and Sub-Saharan Africa (AAPC: 3.1; 95% CI: 0.5, 5.8). The small variation in incidence between regions and the stability in incidence over time suggests that OS carcinogenesis is not influenced by environmental or time-varying exposures.

摘要

骨肉瘤(OS)是儿童和青少年中最常见的原发性骨肿瘤。OS 的病因在很大程度上尚不清楚,但可以通过比较地理区域之间的发病率和趋势来了解。利用 1988 年至 2012 年的《五大洲癌症发病率》(CI5)数据,我们根据年龄组(0-9 岁、10-19 岁、20-29 岁、30-59 岁、60-79 岁和 0-79 岁),呈现了地理区域间 OS 年龄标准化发病率(ASR;每百万病例)和平均年百分比变化(AAPC)及 95%置信区间(CI)。在 10-19 岁年龄组中,我们还使用最新数据(2008-2012 年)呈现了每个国家的 ASR。我们观察到,在 2008-2012 年期间,所有年龄组中,地理区域间 OS 发病率差异不大。总体而言,0-79 岁的 ASR 范围从南亚的每百万 2 例到撒哈拉以南非洲的每百万 4.2 例。随着时间的推移,所有地区的发病率均呈现双峰分布,高峰出现在 10-19 岁和 60-79 岁年龄组。总体而言,1988-2012 年期间,OS 发病率相对稳定,仅在东亚(AAPC:1.8;95%CI:0.6,1.9)和撒哈拉以南非洲(AAPC:3.1;95%CI:0.5,5.8)观察到 0-79 岁年龄组的发病率有统计学意义的增加。区域间发病率的微小差异和随时间的发病率稳定性表明,OS 的致癌作用不受环境或时变暴露的影响。

相似文献

1
International trends in incidence of osteosarcoma (1988-2012).国际骨肉瘤发病率趋势(1988-2012 年)。
Int J Cancer. 2021 Sep 1;149(5):1044-1053. doi: 10.1002/ijc.33673. Epub 2021 May 17.
2
Comparative international incidence of Ewing sarcoma 1988 to 2012.比较 1988 年至 2012 年期间国际上尤因肉瘤的发病率。
Int J Cancer. 2021 Sep 1;149(5):1054-1066. doi: 10.1002/ijc.33674. Epub 2021 May 17.
3
Incidence patterns of primary bone cancer in taiwan (2003-2010): a population-based study.台湾原发性骨癌的发病模式(2003 - 2010年):一项基于人群的研究。
Ann Surg Oncol. 2014 Aug;21(8):2490-8. doi: 10.1245/s10434-014-3697-3. Epub 2014 Apr 11.
4
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.儿童、青少年、中年人和老年人的国际骨肉瘤发病模式。
Int J Cancer. 2009 Jul 1;125(1):229-34. doi: 10.1002/ijc.24320.
5
Trends in paediatric central nervous system tumour incidence by global region from 1988 to 2012.1988 年至 2012 年全球各地区小儿中枢神经系统肿瘤发病趋势。
Int J Epidemiol. 2021 Mar 3;50(1):116-127. doi: 10.1093/ije/dyaa176.
6
Bone cancer incidence by morphological subtype: a global assessment.按形态学亚型划分的骨癌发病率:一项全球评估。
Cancer Causes Control. 2015 Aug;26(8):1127-39. doi: 10.1007/s10552-015-0607-3. Epub 2015 Jun 9.
7
Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.全国范围内未经选择的骨肉瘤患者队列中发病率和生存率的时间趋势。
Acta Oncol. 2015 Jan;54(1):25-33. doi: 10.3109/0284186X.2014.923934. Epub 2014 Jun 24.
8
The epidemiology of osteosarcoma.骨肉瘤的流行病学
Cancer Treat Res. 2009;152:3-13. doi: 10.1007/978-1-4419-0284-9_1.
9
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
10
Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.自1958年以来瑞典骨巨细胞瘤诊断的发病率趋势
J Bone Joint Surg Am. 2015 Nov 4;97(21):1756-66. doi: 10.2106/JBJS.O.00156.

引用本文的文献

1
LncSNHGs: new targets in osteosarcoma.长链非编码RNA SNHGs:骨肉瘤的新靶点
Cancer Gene Ther. 2025 Aug 16. doi: 10.1038/s41417-025-00952-2.
2
Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights.骨肉瘤免疫微环境:细胞斗争与新的治疗见解
Front Immunol. 2025 Jun 4;16:1584450. doi: 10.3389/fimmu.2025.1584450. eCollection 2025.
3
Osteosarcoma cell-derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages.骨肉瘤细胞衍生的CCL2通过肿瘤相关巨噬细胞的积累促进肺转移。
Cancer Immunol Immunother. 2025 May 9;74(7):193. doi: 10.1007/s00262-025-04051-x.
4
Harnessing the metastatic potential of human osteosarcoma cells by natural coumarin galbanic acid.利用天然香豆素没药酸激发人骨肉瘤细胞的转移潜能。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 7. doi: 10.1007/s00210-025-04128-5.
5
Challenges of osteosarcoma care in Africa: a scoping review of the burden, management and outcome.非洲骨肉瘤治疗面临的挑战:对负担、管理和结果的范围综述
Ecancermedicalscience. 2025 Jan 23;19:1835. doi: 10.3332/ecancer.2025.1835. eCollection 2025.
6
SNHG10: A Novel Long Non-coding RNA with Multifaceted Roles in Human Cancers.SNHG10:一种在人类癌症中具有多方面作用的新型长链非编码RNA。
Curr Pharm Des. 2025;31(33):2625-2634. doi: 10.2174/0113816128356231250212050707.
7
Osteosarcoma and Ewing Sarcoma of Bone: An Italian Mono-Institutional Epidemiological Study.骨肉瘤和骨尤文肉瘤:一项意大利单中心流行病学研究。
Diagnostics (Basel). 2025 Jan 30;15(3):328. doi: 10.3390/diagnostics15030328.
8
Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma.FLT3和ALK的联合阻断协同抑制骨肉瘤生长。
Oncogene. 2025 Mar;44(7):427-438. doi: 10.1038/s41388-024-03205-y. Epub 2024 Nov 19.
9
Mesenchymal Stem Cells and Tissue Bioengineering Applications in Sheep as Ideal Model.绵羊作为理想模型中骨髓间充质干细胞与组织生物工程应用
Stem Cells Int. 2024 Oct 18;2024:5176251. doi: 10.1155/2024/5176251. eCollection 2024.
10
Development and validation of a novel endoplasmic reticulum stress-related lncRNAs signature in osteosarcoma.开发和验证骨肉瘤中新型内质网应激相关 lncRNAs 标志物。
Sci Rep. 2024 Oct 26;14(1):25590. doi: 10.1038/s41598-024-76841-9.

本文引用的文献

1
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants.200 个国家和地区 1985 年至 2019 年学龄儿童和青少年的身高和体重指数轨迹:6500 万参与者的 2181 项基于人群的研究的汇总分析。
Lancet. 2020 Nov 7;396(10261):1511-1524. doi: 10.1016/S0140-6736(20)31859-6.
2
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.利用全基因组测序技术对 2658 个人类癌症中的染色体重排进行全面分析。
Nat Genet. 2020 Mar;52(3):331-341. doi: 10.1038/s41588-019-0576-7. Epub 2020 Feb 5.
3
Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.1996 年至 2015 年瑞士软组织和骨肉瘤的发病率、死亡率和生存趋势。
Cancer Epidemiol. 2019 Dec;63:101596. doi: 10.1016/j.canep.2019.101596. Epub 2019 Sep 11.
4
Genetic determinants of childhood and adult height associated with osteosarcoma risk.与骨肉瘤风险相关的儿童和成人身高的遗传决定因素。
Cancer. 2018 Sep 15;124(18):3742-3752. doi: 10.1002/cncr.31645. Epub 2018 Oct 12.
5
Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.非霍奇金淋巴瘤中的第二原发性癌症:双向分析提示免疫功能障碍的作用。
Int J Cancer. 2018 Nov 15;143(10):2449-2457. doi: 10.1002/ijc.31801. Epub 2018 Sep 21.
6
Tumor Syndromes Predisposing to Osteosarcoma.肿瘤综合征与骨肉瘤的相关性。
Adv Anat Pathol. 2018 Jul;25(4):217-222. doi: 10.1097/PAP.0000000000000190.
7
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.国家癌症研究所 Li-Fraumeni 综合征队列基线筛查中的癌症患病率。
JAMA Oncol. 2017 Dec 1;3(12):1640-1645. doi: 10.1001/jamaoncol.2017.1350.
8
International incidence of childhood cancer, 2001-10: a population-based registry study.国际儿童癌症发病率,2001-2010 年:基于人群的注册研究。
Lancet Oncol. 2017 Jun;18(6):719-731. doi: 10.1016/S1470-2045(17)30186-9. Epub 2017 Apr 11.
9
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.成人身高与结直肠癌、肺癌和前列腺癌风险之间的关联:前瞻性研究和孟德尔随机化分析的荟萃分析结果
PLoS Med. 2016 Sep 6;13(9):e1002118. doi: 10.1371/journal.pmed.1002118. eCollection 2016 Sep.
10
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.美国国立癌症研究所李-弗劳梅尼综合征队列中TP53突变携带者首次患癌及后续患癌风险
Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.